Amphastar Pharmaceuticals, Inc.AMPHNASDAQ
Loading
Cash Flow Under PressureContracting
Percentile Rank86
3Y CAGR+23.0%
5Y CAGR+38.9%
Year-over-Year Change
Operating cash flow minus capital expenditures
3Y CAGR
+23.0%/yr
Annual compound
5Y CAGR
+38.9%/yr
Recent deceleration
Percentile
P86
Within normal range
vs 5Y Ago
5.2x
Strong expansion
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $121.23M | -29.7% |
| 2024 | $172.34M | +18.6% |
| 2023 | $145.34M | +123.1% |
| 2022 | $65.15M | -7.6% |
| 2021 | $70.54M | +201.3% |
| 2020 | $23.41M | +11209.7% |
| 2019 | $207000.00 | +102.4% |
| 2018 | $-8.62M | -309.7% |
| 2017 | $4.11M | -76.1% |
| 2016 | $17.18M | - |